Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3328520 | Critical Reviews in Oncology/Hematology | 2016 | 10 Pages |
Abstract
Even though the pathogenesis of myelodysplastic syndromes (MDS) is dominated by specific molecular defects involving hematopoietic precursors, also immune mechanisms seem to play a fundamental functional role. In this review we will first describe the clinical and laboratory autoimmune manifestations often detectable in MDS patients. We will then focus on studies addressing the possible influence of different immune cell subpopulations on the disease onset and evolution. We will finally consider therapeutic approaches based on immunomodulation, ranging from immunosuppressants to vaccination and transplantation strategies.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Claudio Fozza, Valeria Crobu, Maria Antonia Isoni, Fausto Dore,